{"id":899183,"date":"2026-10-29T21:26:09","date_gmt":"2026-10-29T21:26:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/899183\/"},"modified":"2026-10-29T21:26:09","modified_gmt":"2026-10-29T21:26:09","slug":"trump-admin-eases-access-to-unproven-peptides-favored-by-rfk-jr-despite-fda-opposition","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/899183\/","title":{"rendered":"Trump admin eases access to unproven peptides favored by RFK Jr. despite FDA opposition"},"content":{"rendered":"

WASHINGTON \u2014 The Trump administration on Wednesday acted to ease access to unproven peptide drugs<\/a> favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific staffers had little input on the decision and opposed the changes, according to six people familiar with its development.<\/p>\n

The draft policy posted online by Kennedy\u2019s Department of Health and Human Services covers a handful of injectable peptides promoted within the wellness industry for uses such as building muscle, healing injuries and boosting energy. The government will take comments for two weeks before finalizing the measure.<\/p>\n

The document, primarily written by officials at HHS, faced overwhelming pushback among FDA drug staffers who warned it could undermine the agency\u2019s long-standing mission of keeping unsafe health products off the US market, according to the people familiar with its development.<\/p>\n

The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Ron Sachs \u2013 CNP for NY Post<\/p>\n

The draft policy posted online by Kennedy\u2019s Department of Health and Human Services covers a handful of injectable peptides promoted within the wellness industry. Getty Images<\/p>\n

The people spoke to The Associated Press on the condition of anonymity to discuss confidential government deliberations.<\/p>\n

The policy directs the FDA not to take action against specialty pharmacies that sell a half-dozen wellness peptides<\/a>, including BPC-157, TB-500 and KPV. Under normal FDA rules, those chemicals would be considered illegal drugs because they have not gone through the agency\u2019s rigorous review process for safety and effectiveness.<\/p>\n

According to the document posted online, Kennedy determined the change \u201cadvances patient choice and freedom\u201d while protecting people in the United States from peptides sold online that are often made from ingredients of unknown origin and quality.<\/p>\n

Kennedy has called himself a \u201cbig fan\u201d of peptides and previously described using BPC-157 to treat a muscle injury.<\/p>\n

Lee Rosebush of the American Academy of Peptide Medicine said in an online post that HHS had taken \u201ca huge step for patient and provider medical freedom.\u201d The group, which is not a medical professional society, represents people who prescribe or sell peptides.<\/p>\n

The peptide business has caught the attention of major telehealth providers, including Hims & Hers, which recently announced plans to offer wellness peptides once the government changed its policy. Wall Street analysts estimate the market could be worth more than $2 billion.<\/p>\n

Wellness peptides are not FDA approved<\/p>\n

Some peptides occur naturally in the human body, where they trigger hormones needed for growth, metabolism and healing. Drug companies have brought several to market as medications, including mainstay treatments for diabetes and weight loss.<\/p>\n

The chemicals subject to the new policy have not been approved as safe and effective by the FDA. Still, they are promoted online by influencers and celebrities for a range of medical uses, including insomnia<\/a>, anxiety, inflammatory conditions and migraines<\/a>.<\/p>\n

The chemicals subject to the new policy have not been approved as safe and effective by the FDA. SOPA Images\/LightRocket via Getty Images<\/p>\n

Dr. Peter Lurie, a former FDA official, noted that the FDA has already approved rigorously tested drugs for all of those conditions.<\/p>\n

As people \u201care diverted from those drugs toward this stuff, there will be more unnecessary pain and suffering,\u201d said Lurie, who now leads the nonprofit Center for Science in the Public Interest.<\/p>\n

He also questioned the timing of the change, days before the midterm election.<\/p>\n

\u201cThis is a wink and nod to the MAHA faithful in the hope that they\u2019ll show up at the polls,\u201d said Lurie, referring to Kennedy\u2019s \u201cMake America Healthy Again\u201d movement<\/a>.<\/p>\n

RFK Jr. and his MAHA followers support peptides<\/p>\n

A spokesperson for HHS said the agency is \u201cconfronting the risks of black-market peptides\u201d by giving Americans \u201ca more controlled alternative through licensed US compounders.\u201d<\/p>\n

It is the latest example of Kennedy reshaping US health policy in the MAHA mold. Some of the biggest figures in that movement sell peptide injections and supplements.<\/p>\n

The decision is a stark break from past FDA efforts to limit the availability of unproven wellness products, including peptides, stem cell therapies<\/a> and dietary supplements, that make unsupported medical claims. But that approach put the agency at odds with Kennedy, who has publicly endorsed the benefits of all of those products.<\/p>\n

The policy published Wednesday is a step back from HHS\u2019 original plan, according to two of the people who discussed its development.<\/p>\n

HHS officials initially wanted the FDA to draft an official regulation that would add BPC-157 and other peptides to a list of drug substances deemed safe for use by compounding pharmacies, specialty businesses that make customized medications.<\/p>\n

RFK Jr. speaks at a campaign rally at Alico Arena, on Friday, Oct. 23, 2026, in Fort Myers, Florida. AP Photo\/Chris O’Meara<\/p>\n

FDA officials warned that the agency\u2019s scientific staffers had major safety concerns and would not support a regulation deeming the peptides safe. HHS officials moved to a different approach that directs the FDA not to enforce its rules against pharmacies that compound the substances.<\/p>\n

FDA staffers ultimately provided technical assistance in drafting the HHS plan, including guardrails intended to improve safety, such as requiring pharmacies to use peptide ingredients from FDA-registered factories. Additionally, compounders are directed to collect information on side effects for safety analysis and verify the purity of peptides they use.<\/p>\n

Lurie pointed out that the FDA, under federal law, does not have the authority to enforce those pharmacy requirements.<\/p>\n

The Alliance for Pharmacy Compounding, which represents specialty pharmacies, said several details need to be clarified \u2014 including when the policy takes effect and how it will intersect with state pharmacy boards, who traditionally regulate pharmacists.<\/p>\n

Decisions over compounding have long rested with the FDA, not HHS<\/p>\n

Decisions about regulating peptides<\/a> and compounding pharmacies have almost always come from the FDA, which has an office dedicated to protecting US consumers from unsafe or poor-quality compounded drugs.<\/p>\n

The issue of compounding safety became a greater focus for the FDA after a deadly outbreak of fungal meningitis in 2012 was linked to contaminated injections from a Massachusetts compounding pharmacy. Once a niche business, compounding has grown into a multibillion-dollar industry, providing customized medications to doctors, clinics and hospitals.<\/p>\n

\t\t\t\t\t\t\tStart your day with all you need to know\t\t\t\t\t\t<\/p>\n

\n\t\t\t\t\t\t\tMorning Report delivers the latest news, videos, photos and more.\t\t\t\t\t\t<\/p>\n

\t\t\t\t\t\tThanks for signing up!\n\t\t\t\t<\/p>\n

It\u2019s extremely rare for HHS to take the lead in drafting policies over the compounding industry, former FDA officials said. But federal law technically gives HHS authority over drug regulations, which are then delegated to the FDA.<\/p>\n

FDA has warned Americans about safety risks of unproven peptides<\/p>\n

Many in the US who are using peptides today do not deal with a doctor or a pharmacy to get the injections, but often order vials online sold by chemical manufacturers based in China<\/a>. <\/p>\n

Peptide sellers<\/a> often try to skirt US regulations by labeling their products as \u201cfor research use only\u201d because the FDA does not regulate research chemicals.<\/p>\n

In 2023, the FDA added more than a dozen peptides, including BPC-157 and TB-500, to its list of substances that should not be compounded due to risks of allergic reactions, kidney damage and tumor growth.<\/p>\n

At a meeting in July, FDA staffers reiterated that more than half a dozen peptides brought forward for reconsideration remained unproven in terms of safety and effectiveness.<\/p>\n

But a panel of outside experts voted to drop restrictions on the six peptides named in Wednesday\u2019s document. The panel \u2014 selected by Kennedy\u2019s HHS \u2014 included several doctors, pharmacists and consultants who work in the peptide field.<\/p>\n","protected":false},"excerpt":{"rendered":"WASHINGTON \u2014 The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health…\n","protected":false},"author":2,"featured_media":899184,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[246,97,252,44614,253,16766,31442,111,788,15850],"class_list":["post-899183","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-fda","tag-health","tag-health-care","tag-health-department","tag-healthcare","tag-maha","tag-peptides","tag-politics","tag-robert-f-kennedy-jr","tag-scientists"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/899183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=899183"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/899183\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/899184"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=899183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=899183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=899183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}